Piecewise function parameters as responses of the design of experiment in the development of a pulsatile release chronopharmaceutical system

1. A. E. Yassin, A. H. Aodah, S. Al-Suwayeh and E. I. Taha, Theophylline colon specific tablets for chronotherapeutic treatment of nocturnal asthma, Pharm. Dev. Technol. 17 (2012) 712–718; DOI: 10.3109/10837450.2011.572896.10.3109/10837450.2011.572896Search in Google Scholar

2. K. P. Pagar and P. R. Vavia, Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension, Acta Pharm. 62 (2012) 395–410. DOI: 10.2478/v10007-012-0023-0.10.2478/v10007-012-0023-0Search in Google Scholar

3. V. D. Kadam and S. G. Gattani, Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependent polymers, Pharm. Dev. Technol.15 (2010) 57–63; DOI: 10.3109/10837450902980254.10.3109/10837450902980254Search in Google Scholar

4. R. C. Hermida, D. E. Ayala, C. Calvo, F. Portaluppi and M. H. Smolensky, Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure, Adv. Drug Deliv. Rev.59 (2007) 923–39; DOI: 10.1016/j.addr.2006.09.02110.1016/j.addr.2006.09.021Search in Google Scholar

5. F. Portaluppi, R. Tiseo, M. H. Smolensky, R. C. Hermida, D. E. Ayala and F. Fabbian, Circadian rhythms and cardiovascular health, Sleep Med. Rev.16(2) (2012) 151–166; DOI: 10.1016/j.smrv.2011.04.003.10.1016/j.smrv.2011.04.003Search in Google Scholar

6. A. El Sayeh, F. Abou el Ela, E. H. Ibrahim and A. A. Allam, Bucco-adhesive tablets containing metoprolol tartarate: formulation, in vitro and in vivo characterization, J. Drug Del. Sci. Tech.23 (2013) 171–179; DOI: 10.1016/S1773-2247(13)50026-8.10.1016/S1773-2247(13)50026-8Search in Google Scholar

7. H. Ravishankar, P. Patil, A. Samel, H. U. Petereit, R. Lizio and J. Iyer-Chavan, Modulated release metoprolol succinate formulation based on ionic interactions: In vivo proof of concept, J. Control. Release111 (2006) 65–72; DOI: 10.1016/j.jconrel.2005.12.007.10.1016/j.jconrel.2005.12.007Search in Google Scholar

8. R. C. Hermida, D. E. Ayala and F. Portaluppi, Circadian variation of blood pressure: The basis for the chronotherapy of hypertension, Adv. Drug Deliv. Rev.59 (2007) 904–922; DOI: 10.1016/j.addr.2006.08.003.10.1016/j.addr.2006.08.003Search in Google Scholar

9. D. A. Taylor and A. A. Abdel-Rahman, Novel strategies and targets for the management of hypertension, Adv. Pharmacol.57 (2009) 291–345; DOI: 10.1016/S1054-3589(08)57008-6.10.1016/S1054-3589(08)57008-6Search in Google Scholar

10. T. Bussemer and R. A. Bodmeier, Drug Delivery Pulsatile Systems, in Encyclopaedia of Pharmaceutical Technology (Ed. J. Swarbrick) 3^rd ed., Informa Healthcare, New York 2007, pp. 1287–1297.Search in Google Scholar

11. A. Maroni, L. Zema, G. Loreti, L. Palugan and A. Gazzaniga, Film coatings for oral pulsatile release, Int. J. Pharm.457 (2013) 362–371; DOI: 10.1016/j.ijpharm.2013.03.010.10.1016/j.ijpharm.2013.03.01023506956Search in Google Scholar

12. L. Palugan, M. Cerea, L. Zema, A. Gazzaniga and A Maroni, Coated pellets for oral colon delivery, J. Drug Del. Sci. Tech.25 (2015) 1–15; DOI: 10.1016/j.jddst.2014.12.00310.1016/j.jddst.2014.12.003Search in Google Scholar

13. Y. Zhang, M. Huo, J. Zhou, A. Zou, Li W, Yao C and Xie S, DDSolver: an add-in program for modeling and comparison of drug dissolution profiles, AAPS J.12 (2010) 263–71; DOI: 10.1208/s12248-010-9185-1.10.1208/s12248-010-9185-1Search in Google Scholar

14. S. Dash, P. N. Murthy, L. Nath and P. Chowdhury, Kinetic modeling on drug release from controlled drug delivery systems, Acta Pol. Pharm.67 (2010) 217–223.Search in Google Scholar

15. Y. Liu, S. Liu, Q. Dai, Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate, Chem. Pharm. Bull.7 (2009) 55–60; DOI: 10.1248/cpb.57.55.10.1248/cpb.57.55Search in Google Scholar

16. Sigma Plot 11, Statistical User Guide Manual, Systat Software Inc, 2008.Search in Google Scholar

17. A. L. Vonica, I. Tomuţă and S. E. Leucuţa, Experimental design for the screening of three types of coating polymers for metoprolol minitablets with pulsatile release, Farmacia59 (2011) 742–749.Search in Google Scholar

18. I. Tomuţă, C. Alecu, L. L. Rus and S. E. Leucuţa, Optimization of fluid bed formulations of metoprolol granules and tablets using an experimental design, Drug Dev. Ind. Pharm.35 (2009) 1072–1081; DOI: 10.1080/03639040902774149.10.1080/03639040902774149Search in Google Scholar

19. European Pharmacopoeia 8.2. Online Edition 2014.Search in Google Scholar

20. S. Varigonda, T. T. Georgiou, R. A. Siegel and P. Daoutidis, Optimal periodic control of a drug delivery system, Comput. Chem. Eng.32 (2008) 2256–2262; DOI: 10.1016/j.compchemeng.2007.11.003.10.1016/j.compchemeng.2007.11.003Search in Google Scholar

21. H. Wang, J. Li and Y. Kuang, Mathematical modeling and quantitative analysis of insulin therapies, Math. Biosci.210 (2007) 17–33; DOI: 10.1016/j.mbs.2007.05.008.10.1016/j.mbs.2007.05.008Search in Google Scholar

22. L. Eriksson, E. Johansson, N. Kettaneh-Wold, C. Wikström and S. Wold, Design of Experiments, Principles and Applications, 3rd ed., Umetrics Academy, Umea 2008.Search in Google Scholar

23. MODDE 10. Software for Design of Experiments and Optimization: User’s Guide and Tutorial. Umetrics Academy, Umea 2014.Search in Google Scholar

24. I. Tomuţă and S.E. Leucuta, Development and in vitro evaluation of multiparticulate sustained release carbamazepine formulation, Acta Pol. Pharm.69 (2012) 951–964.Search in Google Scholar

25. S. F. Hung, C. M. Hsieh, Y. C. Chen, C. M. Lin, H. O. Ho and M. T. Sheu, Formulation and process optimization of multiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane, Int. J. Pharm.480 (2015) 15–26; DOI: 10.1016/j.ijpharm.2015.01.006.10.1016/j.ijpharm.2015.01.006Search in Google Scholar

26. M. Desai, R. R. Jivani, L. D. Patel, N. P. Jivani and B. Sonagara, Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release, Int. J. Pharm. Investig.2 (2012) 208–212; DOI: 10.4103/2230-973x.107005.10.4103/2230-973X.107005Search in Google Scholar

27. S. Sungthongjeen, S. Puttipipatkhachorn, O. Paeratakul, A. Dashevsky and R. Bodmeier, Development of pulsatile release tablets with swelling and rupturable layers, J. Control. Release95 (2004) 147–159; DOI: 10.1016/j.jconrel..2003.10.023.Search in Google Scholar

28. T. Bussemer, N. A. Peppas and R. Bodmeier, Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system, Eur. J. Pharm. Biopharm.56 (2003) 261–270; DOI: 10.1016/S0939-6411(03)00070-5.10.1016/S0939-6411(03)00070-5Search in Google Scholar